Albendazole Pill

DRUG2 trials

Sponsors

Universidad Nacional de Salta, Barcelona Institute for Global Health

Conditions

HelminthiasisMalaria

Phase 3

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

CompletedNCT04966702

Barcelona Institute for Global HealthMalaria

Start: 2022-03-17End: 2024-10-03Updated: 2025-03-14

Unknown Phase

Urine Albendazole Levels for Coverage Assessment

CompletedNCT04041427

Universidad Nacional de SaltaHelminthiasis

Start: 2019-07-17End: 2020-02-28Updated: 2021-05-11

Related Papers

Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.

2025-11-20

Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique.

2025-11-07

Ivermectin to Control Malaria - A Cluster-Randomized Trial

Open Access CRIS of the University of Bern2025-07-24

Ivermectin to Control Malaria — A Cluster-Randomized Trial

New England Journal of Medicine2025-07-2313 citations

Collateral benefits of ivermectin mass drug administration designed for malaria against headlice in Mopeia, Mozambique: a cluster randomised controlled trial.

2025-03-271 citations

BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators.

2023-06-0410 citations

BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.

2023-02-2127 citations